These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 17354539

  • 21. Status of therapies in development for the treatment of age-related macular degeneration.
    Hunt DW, Margaron P.
    IDrugs; 2003 May; 6(5):464-9. PubMed ID: 12789601
    [Abstract] [Full Text] [Related]

  • 22. Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline.
    Kaiser PK.
    Ophthalmology; 2013 May; 120(5 Suppl):S11-5. PubMed ID: 23642781
    [Abstract] [Full Text] [Related]

  • 23. Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatments.
    Heier JS.
    Ophthalmology; 2013 May; 120(5 Suppl):S23-5. PubMed ID: 23642783
    [Abstract] [Full Text] [Related]

  • 24. Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration.
    Ohr M, Kaiser PK.
    Expert Opin Pharmacother; 2012 Mar; 13(4):585-91. PubMed ID: 22300011
    [Abstract] [Full Text] [Related]

  • 25. Emerging treatments for wet age-related macular degeneration.
    Smith AG, Kaiser PK.
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):157-64. PubMed ID: 24555421
    [Abstract] [Full Text] [Related]

  • 26. Age-related macular degeneration: current and novel therapies.
    Prasad PS, Schwartz SD, Hubschman JP.
    Maturitas; 2010 May; 66(1):46-50. PubMed ID: 20219298
    [Abstract] [Full Text] [Related]

  • 27. Inadvertent injection of intravitreal air during intravitreal Lucentis injection for wet age-related macular degeneration: an undescribed complication.
    Somner JE, Mansfield D.
    Eye (Lond); 2009 Aug; 23(8):1744. PubMed ID: 18836410
    [No Abstract] [Full Text] [Related]

  • 28. [Age related macular degeneration].
    Helgadóttir G, Jónasson F, Sigurdsson H, Magnússon KP, Stefánsson E.
    Laeknabladid; 2006 Oct; 92(10):685-96. PubMed ID: 17062902
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic anti-VEGF in age-related macular degeneration: Ranibizumab and Bevacizumab controversy.
    Moreno SF, Paloma JB.
    Br J Ophthalmol; 2008 Jun; 92(6):866-7. PubMed ID: 18523097
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of wet AMD with less than 12 injections of Ranibizumab per year].
    Gerding H.
    Klin Monbl Augenheilkd; 2010 Apr; 227(4):294-7. PubMed ID: 20408078
    [Abstract] [Full Text] [Related]

  • 31. Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review.
    Boyle J, Vukicevic M, Koklanis K, Itsiopoulos C.
    Psychol Health Med; 2015 Apr; 20(3):296-310. PubMed ID: 25034616
    [Abstract] [Full Text] [Related]

  • 32. Macugen treatment for wet age-related macular degeneration.
    Tobin KA.
    Insight; 2006 Apr; 31(1):11-4. PubMed ID: 16817567
    [Abstract] [Full Text] [Related]

  • 33. [Intravitreal medication for age-related macular degeneration (AMD)].
    Maier M, Fischer E, Winkler von Mohrenfels C, Lohmann C.
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):R1-23; quiz R24-7. PubMed ID: 17260312
    [No Abstract] [Full Text] [Related]

  • 34. Dry age-related macular degeneration: recent progress of therapeutic approaches.
    Kuno N, Fujii S.
    Curr Mol Pharmacol; 2011 Nov; 4(3):196-232. PubMed ID: 21545354
    [Abstract] [Full Text] [Related]

  • 35. Treatment for neovascular age related macular degeneration: The state of the art.
    Eandi CM, Alovisi C, De Sanctis U, Grignolo FM.
    Eur J Pharmacol; 2016 Sep 15; 787():78-83. PubMed ID: 26948315
    [Abstract] [Full Text] [Related]

  • 36. [The role of the vitreous in the pathogenesis of age-related macular degeneration].
    Mennel S, Meyer CH, Schmidt JC.
    Klin Monbl Augenheilkd; 2011 May 15; 228(5):460-4. PubMed ID: 20617491
    [Abstract] [Full Text] [Related]

  • 37. Current choice of treatments for neovascular AMD.
    Lai K, Landa G.
    Expert Rev Clin Pharmacol; 2015 Jan 15; 8(1):135-40. PubMed ID: 25487081
    [Abstract] [Full Text] [Related]

  • 38. Bevasiranib for the treatment of wet, age-related macular degeneration.
    Garba AO, Mousa SA.
    Ophthalmol Eye Dis; 2010 Jan 15; 2():75-83. PubMed ID: 23861616
    [Abstract] [Full Text] [Related]

  • 39. Developments in age-related macular degeneration: Diagnosis and treatment.
    Kaufman SR.
    Geriatrics; 2009 Mar 15; 64(3):16-9. PubMed ID: 19351219
    [Abstract] [Full Text] [Related]

  • 40. New injectable medication effective against wet AMD.
    Morrow T.
    Manag Care; 2006 Aug 15; 15(8):57-8. PubMed ID: 16944636
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.